Is dibutyl phthalate (dbp) safe on skin (left on)?

Under the app's default Cautious lens, dibutyl phthalate (dbp) on skin (left on) rates Swap: the app would put this near the top of your swap plan. 2 sourced concerns count (restricted, consensus tier; endocrine, consensus tier). 1 finding count in its favour. This is research with sources, not medical advice.

What do the Clean, Low, Watch and Swap levels mean?

They are cut from a continuous concern level the app computes from the sourced claims that the chosen evidence lens shows: each claim counts its concern class, tier weight, confidence and dose relevance, combined worst-first with a decay so one serious finding outweighs many small ones, then scaled by how much of the substance reaches you in this use. Clean is below 0.35, Low below 1.1, Watch below 2.0 and Swap above that, on a 0 to 3 scale.

Is Dibutyl Phthalate (dbp) safe when breathed in?

Cosmetics2 uses researched7 sourced claims

Where it turns up: plasticiser, nail polish, endocrine disruptor. Detox My Life researched dibutyl phthalate (dbp) under 2 different uses, because the same substance means something different in each. Every claim below carries its evidence tier, how sure the research is that it applies here, and the sources it cites. The level is computed by the app's own deterministic engine, so the page says exactly what the app would.

Level by use and lens

Use	Mainstream	Cautious (default)	Based	Concerns · favour · fringe
Breathed in	Swap	Swap	Swap	4 · 0
On skin, left on	Swap	Swap	Swap	2 · 1

Mainstream shows consensus claims only; Cautious adds emerging research; Based adds fringe claims, labelled as such. The last column counts, under Cautious, the sourced concerns, the findings in its favour and the fringe claims Based would add.

Safer swaps: the app's swap catalog covers the products this turns up in: Nail polish. Alternatives are always types, never brands.

Breathed in Swap

Under the default Cautious lens dibutyl phthalate (dbp) when breathed in rates Swap: the app would put this near the top of your swap plan. Mainstream (consensus only) rates it Swap; Based (adds the fringe) rates it Swap. Researched 2026-09-03.

Sourced concerns (4)

ConsensusSuspected carcinogenconfidence 100%

The International Agency for Research on Cancer (IARC) has evaluated dibutyl phthalate (DBP) as 'possibly carcinogenic to humans' (Group 2B), based on strong mechanistic evidence and limited evidence for cancer in animals, though evidence in humans is inadequate.

Why here: DBP is widely present in air, including indoor air, due to its use in various products, leading to ubiquitous exposure of the general population through inhalation.
What would have to be true: Ubiquitous inhalation exposure to DBP in indoor and outdoor air; specific carcinogenic thresholds for human inhalation are not established due to inadequate human evidence.

Sources the engine cites:

IARC Monographs evaluation of the carcinogenicity of butyl benzyl phthalate, dibutyl phthalate, and diisononyl phthalate — who.int (2026) · regulator or public body
Di-n-butyl Phthalate | ToxFAQs™ | ATSDR - cdc.gov (2026) · regulator or public body
Introduction - NTP Technical Report on the Toxicology and Carcinogenesis Studies of Di-n-butyl Phthalate (CASRN 84-74-2) Administered in Feed to Sprague Dawley (Hsd:Sprague Dawley® SD®) Rats and B6C3F1/N Mice - NCBI - NIH — nih.gov (2026) · regulator or public body
Dibutyl phthalate (DBP) | CASRN 84-74-2 | DTXSID2021781 | IRIS | US EPA, ORD — epa.gov (1990) · regulator or public body

ConsensusEndocrineconfidence 100%

Dibutyl phthalate is classified as an endocrine disruptor and reproductive toxicant, with regulatory bodies proposing restrictions on its use in articles that cause exposure through inhalation.

Why here: DBP is a semi-volatile compound found in indoor air, released from products like flooring, coated fabrics, and other plastic-containing articles, leading to inhalation exposure.
What would have to be true: Inhalation exposure from consumer products and environmental sources; specific thresholds for endocrine disruption via inhalation are not consistently quantified for general consumer exposure, but regulatory actions indicate concern for exposure from articles.

Sources the engine cites (no regulator, review or study among them):

3 web articles (foodpackagingforum.org, cdxsystem.com, …), linked in the app.
1 community or commercial page, not counted here.

ConsensusIrritant · allergenconfidence 100%

Inhalation of high levels of dibutyl phthalate may cause irritation of the eyes, nose, and throat, as well as nausea, tearing of the eyes, vomiting, dizziness, and headache.

Why here: Dibutyl phthalate is a semi-volatile organic compound that can be released into indoor air from various consumer products and building materials, leading to inhalation exposure.
What would have to be true: High levels of DBP in inhaled air, such as those that may occur in occupational settings or temporarily in poorly ventilated indoor spaces after product use.

Sources the engine cites:

Dibutyl phthalate - DCCEEW — dcceew.gov.au (2026) · regulator or public body
Dibutyl phthalate - NIOSH Pocket Guide to Chemical Hazards - CDC — cdc.gov (2026) · regulator or public body

EmergingIrritant · allergenconfidence 100%

Dibutyl phthalate exposure via inhalation has been linked in animal studies to the aggravation of allergic airway inflammation, promoting inflammatory damage and increasing oxidative stress and apoptosis in lung tissues.

Why here: DBP is a ubiquitous environmental pollutant found in indoor air, and its inhalation can directly impact respiratory health.
What would have to be true: Inhalation of DBP, as demonstrated in animal models with intragastric administration (500-750 mg/kg) and intranasal administration, leading to pulmonary toxicity.

Sources the engine cites:

The aggravation of allergic airway inflammation with dibutyl phthalate involved in Nrf2-mediated activation of the mast cells - PubMed — nih.gov (2021) · regulator or public body
In vivo, in vitro, and in silico approaches in the detailed study of di-butyl phthalate (DBP), a plasticizer-induced lung fibrosis via Nrf-2/Keap-1/HO-1 pathway and its regulation - PubMed — nih.gov (2024) · regulator or public body

On skin, left on Swap

Under the default Cautious lens dibutyl phthalate (dbp) on skin (left on) rates Swap: the app would put this near the top of your swap plan. Mainstream (consensus only) rates it Swap; Based (adds the fringe) rates it Swap. Researched 2026-09-03.

Sourced concerns (2)

ConsensusRestrictedconfidence 100%

Dibutyl phthalate (DBP) is prohibited in cosmetic products in the European Union.

Why here: This regulation directly applies to ingredients in dermal leave-on cosmetic products marketed within the EU.
What would have to be true: Any presence of DBP in cosmetic products intended for dermal leave-on use in the EU.

Sources the engine cites:

Phthalate Regulations in the European Union: An Overview — compliancegate.com (2023) · review
1 web article (measurlabs.com), linked in the app.
1 community or commercial page, not counted here.

ConsensusEndocrineconfidence 100%

Dibutyl phthalate (DBP) is listed by the European Union as an endocrine-disrupting compound of high concern and classified as a reproductive toxicant by the European Chemicals Agency.

Why here: DBP can be systemically absorbed through the skin after topical application from leave-on products, contributing to overall human exposure.
What would have to be true: Dermal exposure from leave-on products containing DBP, leading to systemic absorption.

Sources the engine cites (no regulator, review or study among them):

1 web article (measurlabs.com), linked in the app.
1 community or commercial page, not counted here.

In its favour (1)

ConsensusClearedconfidence 100%

The International Agency for Research on Cancer (IARC) classifies dibutyl phthalate (DBP) as Group 2B, meaning it is possibly carcinogenic to humans, based on strong mechanistic evidence and limited evidence for cancer in animals, but inadequate evidence in humans.

Why here: DBP has been used in cosmetics, and dermal absorption from leave-on products contributes to overall human exposure.
What would have to be true: Dermal exposure from products containing DBP.
The other side: The United States Environmental Protection Agency (USEPA) lists DBP as Group D, not classifiable as to human carcinogenicity, based on inadequate evidence in both humans and animals.

Sources the engine cites:

IARC Monographs evaluation of the carcinogenicity of butyl benzyl phthalate, dibutyl phthalate, and diisononyl phthalate — who.int (2026) · regulator or public body
Dibutyl Phthalate | C16H22O4 | CID 3026 — nih.gov (2025) · regulator or public body
Di-n-butyl Phthalate | ToxFAQs™ | ATSDR — cdc.gov (2001) · regulator or public body
1 web article (oncodaily.com), linked in the app.

Not researched here

The engine has no dossier for dibutyl phthalate (dbp) when cooked with heat, in cold food, as a finishing ingredient, in heated food packaging or other uses. The app researches an ingredient for the use it infers from your product, so a scan fills these in; this page only shows what has already been researched and source-verified.

This is research, not medical advice. Detox My Life shows sourced claims sorted by evidence tier. It does not diagnose, treat, or tell you to start or stop anything. Talk to a qualified professional about your health.

Scan your own. The app reads any product label with your camera, works out how you are about to use it, and researches every ingredient for that use with live sources. Every scan adds to a Detox Score for your home, where 50 is a typical home in your region, and a plan of next swaps.

Download on the App Store Get it on Google Play